Pneumonias associadas à ventilação mecânica por bactérias Gram-negativas em um hospital terciário: aspectos clínicos, epidemiológicos e microbiológicos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Ventilator-associated pneumonia (VAP) is an important cause of healthcareassociated infections, resulting in prolonged hospitalization with increased morbidity
and mortality. Gram-negative bacteria that are highly resistant to antimicrobials have
been associated with VAP. The aim of this study was to assess the occurrence of
VAP caused by Gram-negative bacteria and its clinical, epidemiological and
microbiological aspects in patients hospitalized between 2018 and 2022 in a tertiary
hospital in Juiz de Fora, MG. This is a cross-sectional, retrospective and descriptive
observational study. Clinical, epidemiological and microbiological data were collected
from hospital records and provided by the clinical analysis laboratory. Our results
indicate that 241 patients admitted to a tertiary hospital were diagnosed with VAP
related to gram-negative bacteria. The majority were male (55.6%) and concentrated
in the over-65 age group (54%). Among the most common comorbidities were
diseases of the circulatory system (28.2%). The average length of stay was 42.27 ±
47.93 days and mechanical ventilation time was 26.57 ± 20.44 days. A total of 315
gram-negative bacterial species were isolated from tracheal secretions, the most
common being A. baumanni and K. pneumoniae (22.2%), followed by P. aeruginosa
(20.6%). With regard to the susceptibility profile, K. pneumoniae showed high levels
of resistance to ampicillin/sulbactam (87.1%), ceftazidime (82.9%),
piperacillin/tazobactam (82.6%), cefepime (81.2) and ciprofloxacin and imipenem
(80%). A. baumanni showed high levels of resistance to amikacin and meropenem
(100%), cefepime (97.1%), ciprofloxacin (97.0%), imipenem (95.7%),
ampicillin/sulbactam (95.4%) and ceftazidime (91.3%). For P. aeruginosa, the highest
resistance rates were concentrated in the 50% range, with imipenem (53.3%) and
meropenem (49.2%) standing out. Our results point to the need for knowledge of the
epidemiology and ecology of each hospital environment, contributing to the
construction of infection prevention policies, the containment of antimicrobial
resistance and the rational use of antimicrobials.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

